Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver.
Use the Health Monitor application at http://www.healthsupportsystems.com to search for a drug by brand, generic or symptom
ZIAGEN
Active Ingredients
ABACAVIR SULFATE
Inctive Ingredients
colloidal silicon dioxide,magnesium stearate,microcrystalline cellulose,sodium starch glycolate,hypromellose,polysorbate 80,yellow iron oxide,titanium dioxide,triacetin
Usage
ZIAGEN Tablets and Oral Solution, in combination with other antiretroviral agents, are indicated for the treatment of HIV-1 infection.
Additional important information on the use of ZIAGEN for treatment of HIV-1 infection:
- ZIAGEN is one of multiple products containing abacavir. Before starting ZIAGEN, review medical history for prior exposure to any abacavir-containing product in order to avoid reintroduction in a patient with a history of hypersensitivity to abacavir.
- In one controlled study (CNA30021), more patients taking ZIAGEN 600 mg once daily had severe hypersensitivity reactions than patients taking ZIAGEN 300 mg twice daily.
See WARNINGS, ADVERSE REACTIONS, and Description of Clinical Studies.